Support Services & Resources for More Information on Prostate Cancer

The links below connect you to Web sites developed and maintained by other organizations. We hope you will find them interesting, helpful and informative.

This list of resources is provided as a convenience to you. AstraZeneca takes no responsibility for the content of, or services provided by, these resources and makes no representation as to the accuracy or completeness of any information provided by these resources. AstraZeneca shall have no liability for any damages or injuries of any kind arising from the information provided by the resources listed.

American Cancer Society
250 Williams Street, NW, Suite 600
Atlanta, GA 30303
1-800-ACS-2345 (1-800-227-2345)
www.cancer.org

Call your local chapter of the American Cancer Society at 1-800-ACS-2345.

American Urological Association Foundation (AUAF)
1000 Corporate Boulevard
Linthicum, MD 21090
410-689-3990
1-866-RING-AUA (1-866-746-4282)
www.auafoundation.org

The AUA Foundation is the nation's leading urologic health charity that promotes research, education and advocacy. AUA Foundation's mission is to improve prevention, detection, treatment and ultimately, cure urologic diseases.

CancerCare
275 Seventh Avenue
New York, NY 10001
212-712-8400
1-800-813-HOPE (1-800-813-4673)
www.cancercare.org

CancerCare is a national nonprofit organization that provides free, professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs - including counseling, education, financial assistance and practical help - are provided by trained oncology social workers and are completely free of charge. Founded in 1944, CancerCare provided individual help to more than 97,000 people in 2006-2007, and had nearly 2.1 million visits to its Web sites.

National Cancer Institute (NCI)
NCI Public Inquiries Office
6116 Executive Boulevard, Room 3036A
Bethesda, MD 20892-8322
1-800-4-CANCER (1-800-422-6237)
www.cancer.gov

The National Cancer Institute's Web site (www.cancer.gov) provides accurate, up-to-date information about many types of cancer, information about clinical trials, resources for people dealing with cancer, and information for researchers and health professionals.

National Prostate Cancer Coalition (NPCC)
1154 Fifteenth Street, NW
Washington, DC 20005
202-463-9455
1-888-245-9455
www.fightprostatecancer.org

The National Prostate Cancer Coalition (NPCC), founded in 1996, is the largest advocacy organization dedicated to ending the devastating impact of prostate cancer on men and their families through awareness, outreach and advocacy. The NPCC's goals are educating the public about the disease, reaching out to at risk communities, engaging neighborhoods across the country in advocacy and increasing federal funding for prostate cancer research. NPCC coalition partners include national, regional and local cancer and prostate cancer organizations, associations, clinicians and prostate cancer survivors, their families and friends.

Prostate Cancer Foundation (PCF)
1250 Fourth Street
Santa Monica, CA 90401
310-570-4700
1-800-757-CURE (1-800-757-2873)
www.pcf.org

The Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research to discover better treatments and a cure for recurrent prostate cancer. PCF pursues its mission by reaching out to individuals, corporations and others to harness society's resources--financial and human--to fight this deadly disease. Founded in 1993, the PCF has raised $350 million and provided funding for more than 1,400 research projects at nearly 150 institutions worldwide. The PCF has been a pioneer in the grant making process, simplying paperwork for grantees and leaving more time for scientific investigators to conduct needed research.

The Prostate Net
P.O. Box 2192
Secaucus, NJ 07096-2192
Phone: 1-888-477-6763
www.theprostatenet.org

The Prostate Net develops and maintains an interactive network of educational tools and services for consumers. These services are offered to educate, inform and motivate consumers to make informed choices regarding prostate cancer and other prostate diseases.

Us TOO International Prostate Cancer Education & Support Network
5003 Fairview Avenue
Downers Grove, IL 60515
630-795-1002
1-800-80-UsTOO (1-800-808-7866)
www.ustoo.org

This nonprofit organization provides prostate cancer survivors and their families emotional and educational support through an international network of local support groups. Us TOO offers comprehensive literature and a web site on prostate cancer, a monthly newsletter, the HotSheet, a monthly e-mail, NEWS You Can Use, and a toll-free helpline.

Prescribing Information

Print This Page

Send to a Friend

Change Text Size - A A A

Site Map | Contact Us | Privacy Statement | Legal Information

Important Information About CASODEX (bicalutamide) Tablets

CASODEX at a dose of 50 mg daily is a prescription medication approved for use in combination with an injection of a luteinizing hormone-releasing hormone analog (LHRH-A) for treatment of advanced prostate cancer (metastatic Stage D2).

CASODEX at a dose of 150 mg daily is not approved for use alone or with other treatments. See full Prescribing Information under the section on "CLINICAL PHARMACOLOGY–Clinical Studies–Safety Data from Clinical Studies using CASODEX 150 mg" for additional important safety information regarding CASODEX 150 mg.

Important Safety Information About CASODEX

There have been reports of liver function problems during treatment with CASODEX. Therefore, your doctor will monitor your liver function with a blood test before you start treatment with CASODEX, at regular intervals during the first 4 months of treatment, and at regular times after that.

The most common side effects that occurred during treatment with CASODEX plus an injection of an LHRH-A were hot flashes (53%), pain (21% to 35%, including pelvic, back, and general), weakness (22%), and constipation (22%). Other side effects (reported in 12% to 18% of patients) were urination at night, blood in urine, diarrhea, swelling, shortness of breath, nausea, and infection.

Please click here for full Prescribing Information for CASODEX.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Important Information About ZOLADEX (goserelin acetate implant)

ZOLADEX is a prescription medication approved for use in combination with flutamide (an antiandrogen) plus radiotherapy for locally advanced prostate cancer. Treatment with the combination should start 8 weeks prior to starting and continue during radiation therapy.

ZOLADEX is also approved to use alone for patients with advanced prostate cancer. ZOLADEX may help reduce the size of your cancer and reduce your symptoms (palliative treatment).

Important Safety Information About ZOLADEX

ZOLADEX, like other luteinizing hormone-releasing hormone analogs (LHRH-As), may cause an initial rise in testosterone. When used alone, there may be a temporary worsening of prostate cancer symptoms at the start of therapy.

Common side effects that occurred during treatment with ZOLADEX plus flutamide and radiation therapy or ZOLADEX alone included hot flashes, decrease in sexual desire and/or ability to have erections, diarrhea, pain (general, pelvic, and bone), lower urinary tract symptoms, fatigue, nausea, breast growth, swelling, rash, upper respiratory infection, and sweating.

Please click here for full Prescribing Information for ZOLADEX 3.6 mg 1-month Depot.
Please click here for full Prescribing Information for ZOLADEX 10.8 mg 3-month Depot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

CASODEX and ZOLADEX are registered trademarks of the AstraZeneca group of companies.

This information is intended for US consumers only.

US Corporate Site